Pyruvic Acid
Urine

Pyruvic acid, also known as pyruvate, is a key intermediate in several metabolic pathways throughout the body. Its presence in urine can provide valuable insights into a person's metabolic health and energy production processes. Pyruvic acid is a product of glycolysis, the process by which glucose is broken down to produce energy. After glycolysis, pyruvate can follow several pathways: it can be converted into acetyl-CoA and enter the Krebs cycle for further energy production, or it can be transformed into lactate under anaerobic conditions. Elevated levels of pyruvic acid in urine might indicate issues with carbohydrate metabolism, potential enzyme deficiencies, or problems in the Krebs cycle. Additionally, high pyruvic acid levels can be associated with various metabolic disorders, such as mitochondrial dysfunction or pyruvate dehydrogenase deficiency. Conversely, low levels of pyruvic acid may suggest an inadequate supply of glucose or other substrates necessary for energy production, possibly due to dietary deficiencies or other health conditions. Monitoring pyruvic acid in urine is therefore crucial for understanding and managing various metabolic and health conditions, making it an important marker in assessing overall metabolic function and energy production efficiency.

Pyruvic acid, an intermediate metabolite, plays an important role in linking carbohydrate and amino acid metabolism to the tricarboxylic acid cycle, the fatty acid beta-oxidation pathway, and the mitochondrial respiratory chain complex. Though isolated elevated pyruvate is not diagnostic of any inborn error of metabolism, analysis with lactate may suggest an inborn error of metabolism as some present with lactic acidosis or a high lactate-to-pyruvate (L:P) ratio.

Part of Brain Health

Quest AD-Detect® Phosphorylated tau217 (p-tau217), Plasma What it is: This test measures levels of phosphorylated tau217 (p-tau217) in the blood—a protein strongly linked to the development of Alzheimer’s disease and other neurodegenerative conditions. Tau proteins normally help stabilize nerve cells in the brain. However, when they become abnormally phosphorylated, as seen in Alzheimer’s, they can form toxic tangles that interfere with memory and thinking. Why it matters: The presence of elevated p-tau217 in plasma is a highly specific early indicator of Alzheimer's pathology, even before major symptoms appear. This biomarker is clinically validated to distinguish Alzheimer’s disease from other forms of dementia with greater accuracy than previous tau tests. Who it's for: This test is designed for adults aged 55 and older who are experiencing signs of memory loss, confusion, or cognitive decline. It provides a non-invasive alternative to spinal fluid testing or brain imaging, helping individuals and clinicians detect Alzheimer’s risk earlier and more easily. Clinical insights: Elevated p-tau217 levels are associated with amyloid plaque buildup and neurofibrillary tangles—hallmarks of Alzheimer’s disease. Helps differentiate Alzheimer’s from other neurological conditions such as frontotemporal dementia or Lewy body dementia. Can be used alongside other biomarkers and clinical assessments to improve diagnostic confidence. Takeaway: If you're experiencing cognitive changes or have a family history of Alzheimer’s, the Quest AD-Detect® p-tau217 plasma test offers a powerful, early detection tool—allowing for more informed decisions about brain health, treatment options, and long-term care planning.

People who are new to the GFD encounter new foods and/or over-consume old favorites to compensate for the lack of wheat in the diet. Gluten-free cookies, crackers, breads and cakes often contain copious amounts of rice, amaranth, sorghum and other substitutes. Some of these new-to-the-patient foods may illicit an adverse reaction. Other foods that are often introduced to the patient on the GFD are quinoa, buckwheat and hemp. Some People may turn to the “ancient” grains (Polish wheat, spelt, barley, rye), not knowing that these contain gluten. Another problem patients often face on the GFD is the over-consumption of another starch to make up for the loss of wheat. They turn to potato, rice or corn as a substitute. This can lead to the development of a new sensitivity or the enhancement of old sensitivities.

Antigen Made From: Whole Quinoa kernel Associated With: - Annaphylaxis - Secondary hyperoxaluria Known Cross-Reactions: - Amaranth, Rice, Sunflower; Insulin, Glutamic Acid Decarboxylase-65; Triiodothyronine (T3) Clinical Significance: The presence of antibodies to Quinoa is an indication of food immune reactivity. The offending food and its known cross-reactive foods should be eliminated from the diet. Quinoa is considered a beneficial food, especially for celiac patients and vegetarians. Quinoa is labeled by the scientific community as a nonallergenic food, however, severe allergic reaction to Quinoa has been reported. If a recently diagnosed gluten-reactive patient exhibits high levels of antibodies to Quinoa, it may be due to the late introduction of Quinoa into the diet. References: 1. Astier et al. First case report of anaphylaxis to quinoa, a novel food in France. Allergy, 2009; 64(5):819-820. 2. Jancurova et al. Quinoa – a review. Czech J Food Sci, 2009; 27(2):71-79. 3. Aphalo et al. Surface physicochemical properties of globulin-P amaranth protein. J Agric Food Chem, 2004; 52:616-622. 4. Lee et al. Anaphylaxis to an Organic Health Food Cereal: Amaranth Allergy. J Hum Nutr Diet, 2009, 22:359-363. 5. Kharrazian, et al. Detection of islet cell immune reactivity with low glycemic index foods: is this a concern for type 1 diabetes? J Diabetes Res, 2017; 2017:4124967. 6. Kharrazian, et al. Immunological reactivity using monoclonal and polyclonal antibodies of autoimmune thyroid target sites with dietary proteins. J Thyroid Res, 2017; 2017:4354723.